|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01061 ESSEX BIO-TECH
Nominal 
2.540 -0.190 (-6.960%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 9.937% | 8.085% | 13.093% | 9.732% | 17.150% |
| ROAE (%) | 15.061% | 13.008% | 21.893% | 16.691% | 28.457% |
| Return on Capital Employed (%) | 13.648% | 10.477% | 15.915% | 12.060% | 19.282% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 90.199% | 90.257% | 85.229% | 81.159% | 80.764% |
| EBITDA Margin (%) | 23.814% | 23.150% | 26.061% | 27.839% | 29.928% |
| Pre-tax Profit Margin (%) | 20.276% | 19.757% | 24.087% | 25.647% | 27.493% |
| Net Profit Margin (%) | 16.130% | 17.106% | 21.126% | 22.382% | 23.643% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.536 X | 2.164 X | 2.244 X | 2.199 X | 2.490 X |
| Quick Ratio (X) | 1.458 X | 2.015 X | 2.102 X | 1.957 X | 2.266 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 31.963% | 36.168% | 39.434% | 41.099% | 42.388% |
| Total Debt / Total Assets (%) | 10.398% | 18.055% | 19.738% | 23.242% | 17.772% |
| Net Debt / Total Assets (%) | -7.633% | -1.982% | -3.707% | -1.528% | -5.007% |
| Total Debt / Shareholders' Funds (%) | 15.284% | 28.286% | 32.589% | 39.460% | 30.848% |
| Long Term Debt / Shareholders' Funds (%) | 2.935% | 22.070% | 23.599% | 25.226% | 29.226% |
| Net Debt / Shareholders' Funds (%) | -11.219% | -3.105% | -6.121% | -2.595% | -8.691% |
| Net Cash / (Debt) ($) | 215.823M | 53.752M | 106.150M | 37.009M | 104.045M |
| Net Cash / (Debt) per share ($) | 0.380 | 0.094 | 0.184 | 0.064 | 0.180 |
| Total Debt / Capital Employed (%) | 14.579% | 22.763% | 25.999% | 31.001% | 23.539% |
| Interest Coverage Ratio (X) | 31.861 X | 23.693 X | 43.762 X | 177.484 X | 51.515 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 159.824 Day | 257.630 Day | 184.550 Day | 258.633 Day | 137.084 Day |
| Receivables Turnover (Day) | 108.924 Day | 152.787 Day | 124.291 Day | 200.056 Day | 148.868 Day |
| Payables Turnover (Day) | 2.271 Day | 2.094 Day | 5.411 Day | 18.141 Day | 8.113 Day |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 157,440,000 |
| %Change | -7.285% |
| EPS / (LPS) | HKD 0.277 |
| NBV Per Share ($) | HKD 3.551 |